Reorienting health systems to care for people with HIV beyond viral suppression
Safreed-Harmon, K., Anderson, J., Azzopardi-Muscat, N., Behrens, G.M.N., d'Arminio Monforte, A., Davidovich, U., del Amo, J., Kall, M., Noori, T., Porter, K., Lazarus, J.V.
HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review
Desai, S., Tavoschi, L., Sullivan, A.K., Combs, L., Raben, D., Delpech, V., Jakobsen, S.F., Amato-Gauci, A.J., Croxford, S.
Hepatitis b and c prevalence and incidence in key population groups with multiple risk factors in the EU/ EEA: A systematic review
Mason, L.M.K., Duffell, E., Veldhuijzen, I.K., Petriti, U., Bunge, E.M., Tavoschi, L.
International Society of Cardiovascular Infectious Diseases Guidelines for the Diagnosis, Treatment and Prevention of Disseminated Mycobacterium chimaera Infection Following Cardiac Surgery with Cardiopulmonary Bypass
Hasse B, Hannan MM, Keller PM, Maurer FP, Sommerstein R, Mertz D, Wagner D, FernÃ¡ndez-Hidalgo N, Nomura J, Manfrin V, Bettex D, Hernandez Conte A, Durante-Mangoni E, Tang TH, Stuart RL, Lundgren J, Gordon S, Jarashow MC, Schreiber PW, Niemann S, Kohl TA, Daley CL, et al.
Investing in public health microbiology laboratories in western balkan countries enhances health security from communicable disease threats in Europe
Bajoriniene, A., Leitmeyer, K.C., Struelens, M.J., Kokki, M.H.
Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries
Madeddu, G., Vroling, H., Oordt-Speets, A., Babudieri, S., O'Moore, É., Noordegraaf, M.V., Monarca, R., Lopalco, P.L., Hedrich, D., Tavoschi, L.
Surveillance systems overview for 2017
This spreadsheet contains all surveillance system overview tables from ECDC's annual epidemiological report for 2017.
- Chikungunya virus disease
- Chlamydia infection
- Crimean-Congo haemorrhagic fever
- Ebola haemorrhagic fever
- Hantavirus infection
- Healthcare-associated infections
- Hepatitis A
- Hepatitis B
- Hepatitis C
- HIV infection
- Invasive Haemophilus influenzae disease
- Lassa fever
- Marburg haemorrhagic fever
- Meningococcal disease
- Pneumococcal disease
- Q fever
- Rift Valley fever
- Severe acute respiratory syndrome (SARS)
- Surgical site infections
- Verotoxigenic Escherichia coli infection
- West Nile virus infection
- Yellow fever
Effectiveness of screening and treatment approaches for schistosomiasis and strongyloidiasis in newly-arrived migrants from endemic countries in the EU/EEA: A systematic review
Agbata, E.N., Morton, R.L., Bisoffi, Z., Bottieau, E., Greenaway, C., Biggs, B., Montero, N., Tran, A., Rowbotham, N., Arevalo-Rodriguez, I., Myran, D.T., Noori, T., Alonso-Coello, P., Pottie, K., Requena-Méndez, A.
Public health guidance on prevention and control of blood-borne viruses in prison settings
This document provides EU/EEA Member States with evidence-based scientific advice on available options, when planning and implementing prevention and control interventions for blood-borne viruses in prison settings.
Guidance in brief: Prevention and control of blood-borne viruses in prison settings
This guidance is intended for policymakers responsible for the planning and delivery of healthcare services in the national or sub-national custodial system and all professionals responsible for the health and well-being of people in prison, including community-based service providers and those facilitating continuity of care in the community.